2023 Q2 Form 10-Q Financial Statement

#000095017023016228 Filed on May 01, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q1
Revenue $714.0M $648.0M $479.0M
YoY Change 2.73% 35.28% 190.3%
Cost Of Revenue $245.0M $234.0M $172.0M
YoY Change 12.9% 36.05% 207.14%
Gross Profit $469.0M $414.0M $307.0M
YoY Change -1.88% 34.85% 181.65%
Gross Profit Margin 65.69% 63.89% 64.09%
Selling, General & Admin $278.0M $264.0M $221.0M
YoY Change 2.58% 19.46% 46.36%
% of Gross Profit 59.28% 63.77% 71.99%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $64.00M $64.00M $69.00M
YoY Change -5.88% -7.25% -6.76%
% of Gross Profit 13.65% 15.46% 22.48%
Operating Expenses $364.0M $348.0M $306.0M
YoY Change 1.96% 13.73% 31.9%
Operating Profit $105.0M $80.00M $1.000M
YoY Change -11.76% 7900.0% -100.81%
Interest Expense -$48.00M $60.00M $62.00M
YoY Change -177.42% -3.23% -1.59%
% of Operating Profit -45.71% 75.0% 6200.0%
Other Income/Expense, Net $22.00M $20.00M $16.00M
YoY Change 22.22% 25.0% 128.57%
Pretax Income -$143.0M $35.00M -$56.00M
YoY Change -192.26% -162.5% -70.53%
Income Tax $3.000M $2.000M $0.00
% Of Pretax Income 5.71%
Net Earnings -$150.0M $33.00M -$57.00M
YoY Change -200.0% -157.89% -70.0%
Net Earnings / Revenue -21.01% 5.09% -11.9%
Basic Earnings Per Share -$0.70 $0.15 -$0.24
Diluted Earnings Per Share -$0.70 $0.15 -$0.24
COMMON SHARES
Basic Shares Outstanding 215.6M 222.1M 235.0M
Diluted Shares Outstanding 215.0M 221.0M 235.0M

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $797.0M $842.0M $639.0M
YoY Change 5.15% 31.77% -26.38%
Cash & Equivalents $797.0M $842.0M $639.0M
Short-Term Investments
Other Short-Term Assets $83.00M $55.00M $58.00M
YoY Change 112.82% -5.17% 65.71%
Inventory
Prepaid Expenses
Receivables $134.0M $130.0M $106.0M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $1.014B $1.027B $803.0M
YoY Change 7.19% 27.9% -14.67%
LONG-TERM ASSETS
Property, Plant & Equipment $8.207B $8.198B $8.465B
YoY Change -1.43% -3.15% -7.23%
Goodwill
YoY Change
Intangibles $43.00M $43.00M $44.00M
YoY Change 0.0% -2.27% 0.0%
Long-Term Investments $16.00M
YoY Change 14.29%
Other Assets $45.00M $33.00M $78.00M
YoY Change -61.21% -57.69% 143.75%
Total Long-Term Assets $8.330B $8.526B $8.900B
YoY Change -4.85% -4.2% -6.25%
TOTAL ASSETS
Total Short-Term Assets $1.014B $1.027B $803.0M
Total Long-Term Assets $8.330B $8.526B $8.900B
Total Assets $9.344B $9.553B $9.703B
YoY Change -3.68% -1.55% -7.01%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $279.0M $244.0M $200.0M
YoY Change 32.23% 22.0% 2.04%
Accrued Expenses $228.0M $231.0M $250.0M
YoY Change -7.69% -7.6% 4.17%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $638.0M $592.0M $563.0M
YoY Change 9.62% 5.15% 9.11%
LONG-TERM LIABILITIES
Long-Term Debt $4.490B $4.566B $4.671B
YoY Change -3.87% -2.25% -8.79%
Other Long-Term Liabilities $203.0M $207.0M $184.0M
YoY Change 21.56% 12.5% 37.31%
Total Long-Term Liabilities $4.693B $4.773B $4.855B
YoY Change -3.0% -1.69% -7.61%
TOTAL LIABILITIES
Total Short-Term Liabilities $638.0M $592.0M $563.0M
Total Long-Term Liabilities $4.693B $4.773B $4.855B
Total Liabilities $5.286B $5.365B $5.418B
YoY Change -2.47% -0.98% -6.28%
SHAREHOLDERS EQUITY
Retained Earnings -$165.0M $19.00M -$142.0M
YoY Change -2850.0% -113.38% -176.76%
Common Stock $4.223B $4.218B $4.475B
YoY Change -2.31% -5.74% -1.04%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $4.058B $4.237B $4.333B
YoY Change
Total Liabilities & Shareholders Equity $9.344B $9.553B $9.703B
YoY Change -3.68% -1.55% -7.01%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income -$150.0M $33.00M -$57.00M
YoY Change -200.0% -157.89% -70.0%
Depreciation, Depletion And Amortization $64.00M $64.00M $69.00M
YoY Change -5.88% -7.25% -6.76%
Cash From Operating Activities $146.0M $104.0M $44.00M
YoY Change -0.68% 136.36% -161.97%
INVESTING ACTIVITIES
Capital Expenditures $70.00M $54.00M $21.00M
YoY Change -325.81% 157.14% 320.0%
Acquisitions
YoY Change
Other Investing Activities $1.000M $103.0M $0.00
YoY Change -99.5% -100.0%
Cash From Investing Activities -$69.00M $49.00M -$21.00M
YoY Change -141.07% -333.33% 600.0%
FINANCING ACTIVITIES
Cash Dividend Paid $56.00M $0.00
YoY Change
Common Stock Issuance & Retirement, Net $61.00M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -110.0M -217.0M -69.00M
YoY Change -33.33% 214.49% 885.71%
NET CHANGE
Cash From Operating Activities 146.0M 104.0M 44.00M
Cash From Investing Activities -69.00M 49.00M -21.00M
Cash From Financing Activities -110.0M -217.0M -69.00M
Net Change In Cash -33.00M -64.00M -46.00M
YoY Change -122.0% 39.13% -43.21%
FREE CASH FLOW
Cash From Operating Activities $146.0M $104.0M $44.00M
Capital Expenditures $70.00M $54.00M $21.00M
Free Cash Flow $76.00M $50.00M $23.00M
YoY Change -57.3% 117.39% -130.26%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001617406
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-37795
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
Park Hotels & Resorts Inc.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
36-2058176
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
1775 Tysons Boulevard
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
7th Floor
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Tysons
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
VA
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
22102
CY2023Q1 dei City Area Code
CityAreaCode
571
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
302-5757
CY2023Q1 dei Security12b Title
Security12bTitle
Common Stock, $0.01 par value per share
CY2023Q1 dei Trading Symbol
TradingSymbol
PK
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
215629872
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
8198000000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
8301000000
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
43000000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
43000000
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
842000000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
906000000
CY2023Q1 us-gaap Restricted Cash
RestrictedCash
33000000
CY2022Q4 us-gaap Restricted Cash
RestrictedCash
33000000
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2000000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2000000
CY2023Q1 us-gaap Accounts Receivable Net
AccountsReceivableNet
130000000
CY2022Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
129000000
CY2023Q1 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
55000000
CY2022Q4 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
58000000
CY2023Q1 us-gaap Other Assets
OtherAssets
42000000
CY2022Q4 us-gaap Other Assets
OtherAssets
47000000
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
210000000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
214000000
CY2023Q1 us-gaap Assets
Assets
9553000000
CY2022Q4 us-gaap Assets
Assets
9731000000
CY2023Q1 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
4566000000
CY2022Q4 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
4617000000
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
244000000
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
220000000
CY2023Q1 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
117000000
CY2022Q4 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
141000000
CY2023Q1 us-gaap Other Liabilities
OtherLiabilities
207000000
CY2022Q4 us-gaap Other Liabilities
OtherLiabilities
228000000
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
231000000
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
234000000
CY2023Q1 us-gaap Liabilities
Liabilities
5365000000
CY2022Q4 us-gaap Liabilities
Liabilities
5440000000
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
6000000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
6000000000
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
216317656
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
215630695
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
224573858
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
224061745
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
2000000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
2000000
CY2023Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
4216000000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
4321000000
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
19000000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
16000000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
4237000000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
4339000000
CY2023Q1 us-gaap Minority Interest
MinorityInterest
-49000000
CY2022Q4 us-gaap Minority Interest
MinorityInterest
-48000000
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4188000000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4291000000
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9553000000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9731000000
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
648000000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
479000000
CY2023Q1 us-gaap Cost Of Other Property Operating Expense
CostOfOtherPropertyOperatingExpense
60000000
CY2022Q1 us-gaap Cost Of Other Property Operating Expense
CostOfOtherPropertyOperatingExpense
50000000
CY2023Q1 pk Management And Franchise Fees
ManagementAndFranchiseFees
30000000
CY2022Q1 pk Management And Franchise Fees
ManagementAndFranchiseFees
22000000
CY2023Q1 pk Casualty Loss
CasualtyLoss
1000000
CY2022Q1 pk Casualty Loss
CasualtyLoss
0
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
64000000
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
69000000
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
16000000
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
16000000
CY2023Q1 us-gaap Other Expenses
OtherExpenses
20000000
CY2022Q1 us-gaap Other Expenses
OtherExpenses
16000000
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
583000000
CY2022Q1 us-gaap Costs And Expenses
CostsAndExpenses
478000000
CY2023Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
15000000
CY2022Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
80000000
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
1000000
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
5000000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
35000000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-56000000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2000000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2023Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
10000000
CY2022Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
0
CY2023Q1 us-gaap Interest Expense
InterestExpense
60000000
CY2022Q1 us-gaap Interest Expense
InterestExpense
62000000
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
4000000
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1000000
CY2023Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
50000000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
33000000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-56000000
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0
CY2022Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1000000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
33000000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-57000000
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.15
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.24
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.15
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.24
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
220000000
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
235000000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
221000000
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
235000000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
33000000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-56000000
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
64000000
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
69000000
CY2023Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
15000000
CY2022Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0
CY2023Q1 pk Casualty Loss
CasualtyLoss
1000000
CY2022Q1 pk Casualty Loss
CasualtyLoss
0
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
4000000
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0
CY2023Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
0
CY2022Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
1000000
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
4000000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
4000000
CY2023Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
2000000
CY2022Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
3000000
CY2023Q1 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
6000000
CY2022Q1 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
0
CY2023Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-13000000
CY2022Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-25000000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
104000000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
44000000
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
54000000
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
21000000
CY2023Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
11000000
CY2022Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
0
CY2023Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
116000000
CY2022Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0
CY2023Q1 pk Contributions To Equity Method Investment
ContributionsToEquityMethodInvestment
2000000
CY2022Q1 pk Contributions To Equity Method Investment
ContributionsToEquityMethodInvestment
0
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
49000000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-21000000
CY2022Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
0
CY2023Q1 us-gaap Repayments Of Debt
RepaymentsOfDebt
2000000
CY2022Q1 us-gaap Repayments Of Debt
RepaymentsOfDebt
2000000
CY2023Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
1000000
CY2022Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
3000000
CY2023Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
56000000
CY2022Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
0
CY2023Q1 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
1000000
CY2022Q1 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
0
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2000000
CY2022Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
3000000
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
105000000
CY2022Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
61000000
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-217000000
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-69000000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-64000000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-46000000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
939000000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
763000000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
875000000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
717000000
CY2023Q1 us-gaap Dividends Payable Current
DividendsPayableCurrent
32000000
CY2022Q1 us-gaap Dividends Payable Current
DividendsPayableCurrent
2000000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4291000000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2000000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
33000000
CY2023Q1 us-gaap Dividends
Dividends
32000000
CY2023Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
1000000
CY2023Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
105000000
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4188000000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4403000000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1000000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-56000000
CY2022Q1 us-gaap Dividends
Dividends
2000000
CY2022Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
61000000
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4285000000
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.15
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.01
CY2022Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
994000000
CY2023Q1 us-gaap Construction In Progress Gross
ConstructionInProgressGross
211000000
CY2022Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
201000000
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Use of Estimates</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Interim results are not necessarily indicative of full year performance.</span></p>
CY2023Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Reclassifications</span></p><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certain line items on the audited condensed consolidated balance sheet as of December 31, 2022 have been reclassified to conform to the current period presentation.</span></p>
CY2023Q1 us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
15000000
CY2023Q1 us-gaap Land
Land
3272000000
CY2022Q4 us-gaap Land
Land
3317000000
CY2023Q1 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
6469000000
CY2022Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
6512000000
CY2023Q1 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
993000000
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
10945000000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
11024000000
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2747000000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2723000000
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
8198000000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
8301000000
CY2023Q1 us-gaap Depreciation Nonproduction
DepreciationNonproduction
64000000
CY2022Q1 us-gaap Depreciation Nonproduction
DepreciationNonproduction
68000000
CY2023Q1 pk Number Of Consolidated Variable Interest Entities
NumberOfConsolidatedVariableInterestEntities
3
CY2023Q1 pk Number Of Unconsolidated Joint Ventures
NumberOfUnconsolidatedJointVentures
4
CY2022Q4 pk Number Of Unconsolidated Joint Ventures
NumberOfUnconsolidatedJointVentures
4
CY2023Q1 pk Unconsolidated Affiliate Debt
UnconsolidatedAffiliateDebt
721000000
CY2022Q4 pk Unconsolidated Affiliate Debt
UnconsolidatedAffiliateDebt
721000000
CY2023Q1 pk Longterm Debt And Financing Lease Obligations Gross
LongtermDebtAndFinancingLeaseObligationsGross
4592000000
CY2022Q4 pk Longterm Debt And Financing Lease Obligations Gross
LongtermDebtAndFinancingLeaseObligationsGross
4644000000
CY2023Q1 us-gaap Debt Instrument Unamortized Premium
DebtInstrumentUnamortizedPremium
2000000
CY2022Q4 us-gaap Debt Instrument Unamortized Premium
DebtInstrumentUnamortizedPremium
3000000
CY2023Q1 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
28000000
CY2022Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
30000000
CY2023Q1 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
4566000000
CY2022Q4 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
4617000000
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
861000000
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
7000000
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
657000000
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
1563000000
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
30000000
CY2023Q1 pk Long Term Debt Maturities Repayments Of Principal After Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour
1474000000
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
4592000000
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4000000
CY2023Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
32000000
CY2023Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y1M6D
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
6000000
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
6000000
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.480
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.043
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P3Y
CY2023Q1 pk Net Income Attributable To Stockholders Net Of Earnings Allocated To Participating Securities
NetIncomeAttributableToStockholdersNetOfEarningsAllocatedToParticipatingSecurities
33000000
CY2022Q1 pk Net Income Attributable To Stockholders Net Of Earnings Allocated To Participating Securities
NetIncomeAttributableToStockholdersNetOfEarningsAllocatedToParticipatingSecurities
-57000000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
220000000
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
235000000
CY2023Q1 us-gaap Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends
IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends
1
CY2022Q1 us-gaap Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends
IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends
0
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
221000000
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
235000000
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.15
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.24
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.15
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.24
CY2023Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
648000000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
479000000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
33000000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-56000000
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
64000000
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
69000000
CY2023Q1 pk Corporate General And Administrative Expenses Excluding Severance
CorporateGeneralAndAdministrativeExpensesExcludingSeverance
16000000
CY2022Q1 pk Corporate General And Administrative Expenses Excluding Severance
CorporateGeneralAndAdministrativeExpensesExcludingSeverance
16000000
CY2023Q1 pk Casualty Loss
CasualtyLoss
1000000
CY2022Q1 pk Casualty Loss
CasualtyLoss
0
CY2023Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
20000000
CY2022Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
16000000
CY2023Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
15000000
CY2022Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0
CY2023Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
10000000
CY2022Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
0
CY2023Q1 us-gaap Interest Expense
InterestExpense
60000000
CY2022Q1 us-gaap Interest Expense
InterestExpense
62000000
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
4000000
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2000000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1000000
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
5000000
CY2023Q1 pk Other Items
OtherItems
-6000000
CY2022Q1 pk Other Items
OtherItems
-3000000
CY2023Q1 pk Adjusted Ebitda
AdjustedEbitda
152000000
CY2022Q1 pk Adjusted Ebitda
AdjustedEbitda
89000000
CY2023Q1 us-gaap Assets
Assets
9553000000
CY2022Q4 us-gaap Assets
Assets
9731000000
CY2023Q1 us-gaap Purchase Commitment Remaining Minimum Amount Committed
PurchaseCommitmentRemainingMinimumAmountCommitted
168000000
CY2023Q1 us-gaap Litigation Reserve
LitigationReserve
8000000

Files In Submission

Name View Source Status
0000950170-23-016228-index-headers.html Edgar Link pending
0000950170-23-016228-index.html Edgar Link pending
0000950170-23-016228.txt Edgar Link pending
0000950170-23-016228-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pk-20230331.htm Edgar Link pending
pk-20230331.xsd Edgar Link pending
pk-ex31_1.htm Edgar Link pending
pk-ex31_2.htm Edgar Link pending
pk-ex32_1.htm Edgar Link pending
pk-ex32_2.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
pk-20230331_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
pk-20230331_def.xml Edgar Link unprocessable
pk-20230331_pre.xml Edgar Link unprocessable
pk-20230331_lab.xml Edgar Link unprocessable
pk-20230331_htm.xml Edgar Link completed
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending